In 1988, a new strain of avian leukosis virus (ALV) was isolated from meat-type chickens in the UK. Studies on the prototype virus strain, HPRS-103, placed it in a new envelope subgroup, designated J. The envelope gene of subgroup J ALV (ALV-J) is closely related to endogenous retroviral sequences of the EAV family present in the normal chicken genome, suggesting that ALV-J is a genetic recombinant. Sequence studies on the envelope gene of various field isolates of ALV-J indicate the occurrence of frequent mutations leading to antigenic variation. Experimentally and in the field, HPRS-103 and related viruses cause predominantly myeloid leukosis (myelocytomatosis: ML) and a variety of less common tumours, with experimentally a latent period between infection and the onset of ML mortality of 9 or more weeks and a median age at death of 20 weeks. The frequency of tumours varies considerably between lines of chickens. From some cases of ML, acutely-transforming variant viruses can be isolated which are more rapidly tumourigenic. Cell tropism studies revealed that HPRS-103 has a low tropism for bursal follicle cells, but high tropism for cultured blood monocytes. ALV-J can be detected in the field using conventional ALV isolation and characterization methods. Recently, PCR assays specific for ALV-J have been developed. Serum antibodies to ALV-J can be detected using virus neutralization techniques and ELISA tests using crude antigen from ALV-J infected fibroblasts or purified antigen produced in a baculovirus system. ALV-J spreads vertically through the embryo and horizontally by contact, producing tolerant viraemic birds and immune birds, respectively. All birds of the former class are shedders and transmitters of ALV-J to their progeny, as are a few birds in the immune class. Meat-type birds infected soon after hatching are particularly prone to becoming tolerant also. Shedder hens can be identified by testing vaginal swabs and egg albumen for ALV group-specific antigen by an ELISA, allowing ALV-J eradication protocols to be designed. Commercial application of such an eradication programme over several years has resulted in a marked reduction in the prevalence of virus in infected breeding flocks.